TMEM38B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.693400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.556000E-01
Normal-vs-Stage2
8.704400E-01
Normal-vs-Stage3
7.863800E-03
Normal-vs-Stage4
6.733800E-01
Stage1-vs-Stage2
1.536040E-01
Stage1-vs-Stage3
5.934400E-02
Stage1-vs-Stage4
3.027800E-01
Stage2-vs-Stage3
3.46839999998405E-06
Stage2-vs-Stage4
6.137200E-01
Stage3-vs-Stage4
7.348200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.643800E-01
Normal-vs-AfricanAmerican
5.313600E-01
Normal-vs-Asian
6.671600E-01
Caucasian-vs-AfricanAmerican
8.652600E-01
Caucasian-vs-Asian
5.652100E-02
AfricanAmerican-vs-Asian
1.646240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.707400E-01
Normal-vs-Female
2.069600E-01
Male-vs-Female
5.589800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.067400E-01
Normal-vs-Age(41-60Yrs)
1.042630E-01
Normal-vs-Age(61-80Yrs)
8.384400E-01
Normal-vs-Age(81-100Yrs)
9.978600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.866000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.382600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.902200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.433800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.155650E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.588800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.758400E-01
Normal-vs-Daily Drinker
9.041400E-01
Normal-vs-Weekly Drinker
8.513000E-01
Normal-vs-Occasional Drinker
1.909220E-01
Normal-vs-Social Drinker
3.143800E-01
Non Drinker-vs-Daily Drinker
4.786200E-01
Non Drinker-vs-Weekly Drinker
4.566800E-01
Non Drinker-vs-Occasional Drinker
1.434840E-01
Non Drinker-vs-Social Drinker
2.563000E-01
Daily Drinker-vs-Weekly Drinker
9.225400E-01
Daily Drinker-vs-Occasional Drinker
2.389400E-01
Daily Drinker-vs-Social Drinker
3.659200E-01
Weekly Drinker-vs-Occasional Drinker
2.644800E-01
Weekly Drinker-vs-Social Drinker
3.927000E-01
Occasional Drinker-vs-Social Drinker
9.318800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.465600E-01
Normal-vs-Grade 2
7.213000E-01
Normal-vs-Grade 3
6.623800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.818100E-02
Grade 1-vs-Grade 3
6.249800E-02
Grade 1-vs-Grade 4
5.465600E-01
Grade 2-vs-Grade 3
6.755000E-01
Grade 2-vs-Grade 4
7.213000E-01
Grade 3-vs-Grade 4
6.623800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.263600E-01
Normal-vs-NonDiabetic
2.507600E-01
Diabetic-vs-NonDiabetic
5.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.577800E-01
Normal-vs-NoPancreatitis
1.841550E-01
Pancreatitis-vs-NoPancreatitis
2.505000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.859580E-01
Normal-vs-N1
8.381000E-01
N0-vs-N1
2.532200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.369000E-01
Normal-vs-TP53-NonMutant
6.525700E-02
TP53-Mutant-vs-TP53-NonMutant
1.418310E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
